Medicines With The Active Ingredient Infliximab - In The Dosage Form Injection Solution (Atc: L04Ab02)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 72080879

  Document Type - Tender Notices

Description - The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient infliximab - in the dosage form injection solution (ATC: L04AB02) as part of a so-called "open-house model". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130 a Paragraph 8 SGB V for the active ingredients mentioned in Section B. Interested pharmaceutical companies can request the participation documents

Gt Ref Id - 72080879

Deadline - Aug 31, 2025